Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: Results from a case-control study in Taiwan

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 777-784

  Wu, Mei Hsuan ^a   Chu, Chi Hong ^b   Chou, Yu Ching ^c   Chou, Wan Yun ^a   Yang, Tsan ^d   Hsu, Giu Cheng ^b   Yu, Cheng Ping ^b   Yu, Jyh Cherng ^b   Sun, Chien An ^a,b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d MEIHO UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Case control study; Haplotype; Peroxisome proliferator activated receptor ; Polymorphism

Indexed keywords

ESTROGEN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CODOMINANCE; CONTROLLED STUDY; ENZYME ASSAY; ETHNICITY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RECESSIVE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; WAIST CIRCUMFERENCE;

ADULT; AGED; AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; RISK FACTORS; TAIWAN;

EID: 79958249963     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1282-4     Document Type: Article

References (34)

1. EE Calle R Kaaks 2004 Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 579 591 15286738 10.1038/nrc1408 1:CAS:528:DC%2BD2cXmtVOhsLk%3D (Pubitemid 39025053)
2. DP Rose D Komninou GD Stephenson 2004 Obesity, adipocytokines, and insulin resistance in breast cancer Obes Rev 5 153 165 15245384 10.1111/j.1467-789X.2004.00142.x 1:CAS:528:DC%2BD2cXnt1Skurs%3D (Pubitemid 38998240)
3. J Auwerx 1999 PPARgamma, the ultimate thrifty gene Diabetologia 42 1033 1049 10447513 10.1007/s001250051268 1:CAS:528:DyaK1MXlsF2ntr4%3D (Pubitemid 29408799)
4. B Desvergne W Wahli 1999 Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr Rev 20 649 688 10529898 10.1210/er.20.5.649 1:CAS:528:DyaK1MXmvFalsLo%3D (Pubitemid 30650602)
5. J Berger D Moller 2002 The mechanisms of action of PPARs Annu Rev Med 53 409 435 11818483 10.1146/annurev.med.53.082901.104018 1:CAS:528: DC%2BD38Xitl2mt7s%3D (Pubitemid 34177889)
6. RN DuBois R Gupta J Brockman BS Reddy SL Krakow MA Lazar 1998 The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers Carcinogenesis 19 49 53 9472692 10.1093/carcin/19.1.49 1:CAS:528: DyaK1cXpsVCguw%3D%3D (Pubitemid 28376825)
7. LD Yee CL Sabourin L Liu HM Li PJ Smith V Seewaldt DA Kniss 1999 Peroxisome proliferator-activated receptor gamma activation in human breast cancer Int J Oncol 15 967 973 10536181 1:CAS:528:DyaK1MXnsFGisLY%3D
8. MR Smith PW Kantoff 2002 Peroxisome proliferator-activated receptor gamma (PPARgamma) as a novel target for prostate cancer Invest New Drugs 20 195 200 12099579 10.1023/A:1015670126203 1:CAS:528:DC%2BD38XkvFersrg%3D (Pubitemid 34632654)
9. N Suh Y Wang CR Williams R Risingsong T Gihmer TM Willson MB Sporn 1999 A new ligand for the peroxisome proliferator-activated receptor-γ (PPAR-γ), GW7845, inhibits rat mammary carcinogenesis Cancer Res 59 5671 5673 10582681 1:CAS:528:DyaK1MXnslyht7w%3D
10. RG Mehta E Williamson MK Patel HP Koeffler 2000 A ligand of peroxisome proliferator-activated receptor-γ (PPARγ), retinoids and prevention of preneoplastic mammary lesions J Natl Cancer Inst 92 418 423 10699072 10.1093/jnci/92.5.418 1:CAS:528:DC%2BD3cXhvFGhu7o%3D (Pubitemid 30154824)
11. E Mueller P Sarraf P Tontonoz RM Evans KJ Martin M Zhang C Fletcher S Singer BM Spiegelman 1998 Terminal differentiation of human breast cancer through PPAR gamma Mol Cell 1 465 470 9660931 10.1016/S1097-2765(00)80047-7 1:CAS:528:DyaK1cXhtlyhurk%3D (Pubitemid 128378895)
12. GL Rubin Y Zhao AM Kalus ER Simpson 2000 Peroxisome proliferator- activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy Cancer Res 60 1604 1608 10749129 1:CAS:528:DC%2BD3cXit1aqt7c%3D (Pubitemid 30183431)
13. T Suzuki S Hayashi Y Miki Y Nakamura T Moriya A Sugawara T Ishida N Ohuchi H Sasano 2006 Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions Endocr Relat Cancer 13 233 250 16601291 10.1677/erc.1.01075 1:CAS:528:DC%2BD28XltlKrsr4%3D
14. CJ Yen BA Beamer C Negri K Silver KA Brown DP Yarnall DK Burns J Roth AR Shuldiner 1997 Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation Biochem Biophys Res Commun 241 270 274 9425261 10.1006/bbrc.1997.7798 1:CAS:528:DyaK1cXhtlCgtg%3D%3D (Pubitemid 28020091)
15. SS Deeb L Fajas M Nemoto J Pihlajamäki L Mykkänen J Kuusisto M Laakso W Fujimoto J Auwerx 1998 A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nat Genet 20 284 287 9806549 10.1038/3099 1:CAS:528: DyaK1cXntFOhsL8%3D (Pubitemid 28507675)
16. A Meirhaeghe L Fajas N Helbecque D Cottel P Lebel J Dallongville S Deeb J Auwerx P Amouyel 1998 A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans Hum Mol Genet 7 435 440 9467001 10.1093/hmg/7.3.435 1:CAS:528:DyaK1cXitFWmt74%3D (Pubitemid 28120633)
17. R Valve K Sivenius R Miettinen J Pihlajamaki A Rissanen SS Deeb J Auwerx M Uusitupa M Laakso 1999 Two polymorphisms in the peroxisome proliferator-activated receptor gamma gene are associated with severe overweight among obese women J Clin Endocrinol Metab 84 3708 3712 10523018 10.1210/jc.84.10.3708 1:CAS:528:DyaK1MXms1Ohur8%3D (Pubitemid 30645229)
18. A Meirhaeghe L Fajas F Gouilleux D Cottel N Helbecque J Auwerx P Amouyel 2003 A functional polymorphism in a STAT5b site of the human PPAR 3 gene promoter affects height and lipid metabolism in a French population Arterioscler Thromb Vasc Biol 23 289 294 12588773 10.1161/01.ATV.0000051382.28752.FE 1:CAS:528:DC%2BD3sXptFyrsg%3D%3D (Pubitemid 36231942)
19. MH Wu YC Chou WY Chou GC Hsu CP Yu JC Yu CM Chu CA Sun 2009 Circulating levels of leptin, adiposity and breast cancer Br J Cancer 100 578 582 19223908 10.1038/sj.bjc.6604913 1:CAS:528:DC%2BD1MXit1Oktbw%3D
20. MH Wu YC Chou WY Chou GC Hsu CH Chu CP Yu JC Yu CA Sun 2010 Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: evidence from a case-control study Int J Cancer 126 508 514 19585556 10.1002/ijc.24722 1:CAS:528:DC%2BD1MXhsFGjsrrO
21. GA Colditz AL Frazier 1995 Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus Cancer Epidemiol Biomarkers Prev 4 567 571 7549816 1:STN:280:DyaK28%2FlsFGmug%3D%3D
22. MH Wu YC Chou JC Yu CP Yu CC Wu CM Chu T Yang CH Lai CY Hsieh SL You CJ Chen CA Sun 2006 Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area Ann Epidemiol 16 223 229 15996484 10.1016/j.annepidem.2005.02.015 (Pubitemid 43259542)
23. J Barrett B Fry J Maller M Daly 2005 Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 263 265 15297300 10.1093/bioinformatics/bth457 1:CAS:528:DC%2BD2MXkt1WitQ%3D%3D (Pubitemid 40202029)
24. J Long R Williams M Urbanek 1995 An E-M algorithm and testing strategy for multiple-locus haplotypes Am J Hum Genet 56 799 810 7887436 1:STN:280:DyaK2M7ptlyisg%3D%3D
25. Kleinbaum D, Kupper L, Muller K (1998) Applied regression analysis and other multivariate methods. PWS-KENT, Boston
26. A Memisoglu S Hankinson J Manson G Colditz D Hunter 2002 Lack of association of the codon 12 polymorphism of the peroxisome proliferator- activated receptor gamma gene with breast cancer and body mass Pharmacogenetics 12 597 603 12439219 10.1097/00008571-200211000-00003 1:CAS:528: DC%2BD38XovVeitLk%3D (Pubitemid 36005668)
27. U Vogel J Christensen B Nexø H Wallin S Friis A Tjønneland 2007 Peroxisome proliferator-activated receptor γ2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes Carcinogenesis 28 427 434 16959787 10.1093/carcin/bgl170 1:CAS:528:DC%2BD2sXhs1Srs7o%3D (Pubitemid 46321860)
28. Y Wang M McCullough V Stevens C Rodriguez E Jacobs L Teras A Pavluck M Thun E Calle 2007 Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer Anticancer Res 27 589 593 17348446 1:CAS:528:DC%2BD2sXjs12msrs%3D (Pubitemid 46374981)
29. A Doney B Fischer D Frew A Cumming DM Flavell M World HE Montgomery D Boyle A Morris CN Palmer 2002 Haplotype analysis of the PPARGgamma Pro12Ala and C1431T variants reveals opposing associations with body weight BMC Genet 3 21 29 12429071 10.1186/1471-2156-3-21 (Pubitemid 38751028)
30. ES Tai D Corella M Deurenberg-Yap X Adiconis SK Chew CE Tan JM Ordovas 2004 Differential effects of the C1431T and Pro12Ala PPARγ gene variants on plasma lipids and diabetes risk in an Asian population J Lipid Res 45 674 685 14729856 10.1194/jlr.M300363-JLR200 1:CAS:528:DC%2BD2cXjtFWmsb4%3D (Pubitemid 38405674)
31. WM Smith XP Zhou K Kurose X Gao F Latif T Kroll K Sugano SA Cannistra SK Clinton ER Maher TW Prior C Eng 2001 Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases Hum Genet 109 146 151 11511919 10.1007/s004390100563 1:CAS:528:DC%2BD3MXmtVWitLw%3D (Pubitemid 32825554)
32. JD Yager NE Davidson 2006 Estrogen carcinogenesis in breast cancer N Engl J Med 354 270 282 16421368 10.1056/NEJMra050776 1:CAS:528: DC%2BD28Xls1KjtQ%3D%3D (Pubitemid 43113032)
33. CS Huang CH Lin YS Lu CY Shen 2010 Unique features of breast cancer in Asian women: breast cancer in Taiwan as an example J Steroid Biochem Mol Biol 118 300 303 20045728 10.1016/j.jsbmb.2009.12.017 1:CAS:528:DC%2BC3cXitlSlu70%3D
34. S Wacholder DT Silverman JK McLaughlin DT Silverman JS Mandel 1992 Selection of controls in case-control studies. I. Principles Am J Epidemiol 135 1019 1028 1595688 1:STN:280:DyaK383otVOqtQ%3D%3D